MIMS Education

IPD in adults: Updates to epidemiology, vaccines & guideline recommendations

IPD in adults: Updates to epidemiology, vaccines & guideline recommendations

Infectious DiseasesPaediatricsGeneral Practice
A badge with ribbon in color black CME Unit: 1 point | An analog clock in color black 40 Minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 05 Apr 2025 

Overview

About this course

This module will explore the changing trends of invasive pneumococcal disease (IPD) in adults, including the evolving landscape of IPD in the post-COVID era, the significance of serotype 3 IPD and the need for protection against it. With the recent availability of 20-valent pneumococcal conjugate vaccine (PCV20) in Hong Kong, this module will also examine how PCV20 compares with the currently available adult pneumococcal vaccines, based on key clinical data and differences in serotype coverages. Lastly, the module will cover updated global and local recommendations for adult pneumococcal vaccinations and PCV20 integration into existing vaccine schedules.

Learning outcomes

Upon completion of this module, participants should be able to:

  • Acknowledge the rising trend of adult IPD cases in the post-COVID era
  • Recognise the currently available adult pneumococcal vaccines and differences in their serotype coverage against IPD
  • Understand the significance of serotype 3 IPD in Hong Kong and the need for protection against it
  • Summarise safety and immunogenicity findings from key clinical trials comparing PCV20 with PCV13 or PPSV23 in adults who are vaccine-naive or vaccine-experienced, and with those co-administered with influenza and COVID-19 booster vaccines
  • Recognise the immunogenicity comparison of PCV15 with other pneumococcal vaccines for all serotypes
  • Understand global and local recommendations for adult pneumococcal vaccinations, including the integration of PCV20 into vaccine schedules for specific countries

Topics covered

  • IPD in the post-COVID era
  • Adult pneumococcal vaccines and their coverage
  • Relevance of serotype 3 pneumococcal disease and protection against it
  • Key clinical evidence of PCV20 in adults
  • PCV15 versus other pneumococcal vaccines for adults
  • Recommendations for adult pneumococcal vaccinations

1 CME Point Available

  • This module is accredited for 1 CME Point for medical practitioners enrolled in The Medical Council of Hong Kong’s Continuing Medical Education Programme for Practising Doctors who are not taking CME for Specialists.
  • This module is accredited for 1 CME Point for fellows of The Hong Kong College of Pathologists, Hong Kong College of Paediatricians, Hong Kong College of Community Medicine, and 0.5 CME point for fellows of Hong Kong College of Physicians.
  • Please note that this module will not earn CME credit for fellows of colleges not listed here.
  • A certificate can be downloaded upon successful completion of the quiz. Please use the information on the certificate to claim your CME points.